Elevance Health Inc. (ELV) Misses Q3 EPS by $1.29, Beats on Revenue

Elevance Health Inc. (NYSE: ELV) reported Q3 EPS of $8.37, $1.29 worse than the analyst estimate of $9.66. Revenue for the quarter came in at $44.7 billion versus the consensus estimate of $43.46 billion.

For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Qualcomm (QCOM) PT Raised to $195 at BofA Securities
• Apollo Private Credit Fund caps redemptions at 5% - Bloomberg